The content on this site is intended for healthcare professionals only
Cetuximab and docetaxal for squamous cell cancer of the head and neck, from ASCO 2008
Published: 27 Nov 2008
Views: 16295
Professor Jan B. Vermorken
- Categories:
- Head & neck
Related Videos
War in Ukraine: Impacts on the Ukrainian cancer care system
Dr Andriy Hrynkiv
4 May 2022
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid ...
Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
14 Apr 2022
Survival outcomes of unilateral RB based on pathological risk stratification-exp...
Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre...
1 Mar 2022
OncoAlert and ecancer - ESMO 2021 Day 5
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
21 Sep 2021
Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative ch...
Prof John Reynolds - Trinity College Dublin, Dublin, Republic of Ireland
29 Jun 2021
COSMIC-311: Cabozantinib versus placebo in patients with radioiodine-refractory ...
Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA
29 Jun 2021
Incidence and trends of HPV-related cancers in the United States
Dr John Chan - UCSF Helen Diller Family Comprehensive Cancer Center, San Francis...
4 Jun 2021
Nivolumab plus ipilimumab or NIVO plus chemo versus chemo as firstline for advan...
Dr Ian Chau - The Royal Marsden, London, UK
4 Jun 2021
2020 updates in treating NTRK fusion cancer
Dr Alexander Drilon and Prof Marc Peeters
22 Dec 2020